What length of time is typically required to determine whether ECP has been effective for cGVHD, and when might you consider discontinuation of ECP based on a clinical response to ECP? What is the accepted tapering schedule in responders?

What length of time is typically required to determine whether ECP has been effective for cGVHD, and when might you consider discontinuation of ECP based on a clinical response to ECP? What is the accepted tapering schedule in responders?

What length of time is typically required to determine whether ECP has been effective for cGVHD, and when might you consider discontinuation of ECP based on a clinical response to ECP? What is the accepted tapering schedule in responders?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Daniel Couriel, MD, MS

Daniel Couriel, MD, MS

Daniel R. Couriel, MD, MS
Professor of Internal Medicine
Director, Huntsman Cancer Institute (HCI) Blood and Marrow Transplant Program
University of Utah School of Medicine
Salt Lake City, UT